本文报告40例肺癌患者的血红蛋白、红细胞测定结果。结果表明,肺癌患者贫血的发生率为40%,明显高于对照组。这种继发于肺癌的贫血与肺癌本身病变、病期、年龄及化疗等因素密切相关。肺癌所致贫血是一种进行性的不易纠正的贫血,是肺癌预后不良的一个因素。作者建议,对广泛型65岁以上的患者化疗对应慎重,宜代之以增强机体抵抗力的支持疗法,可能更有利于延长患者的生命。 This article reports 40 cases of lung cancer patients hemoglobin, erythrocyte assay results. The results showed that the incidence of anemia in lung cancer patients was 40%, significantly higher than the control group. This anemia secondary to lung cancer and lung disease itself, disease, age and chemotherapy and other factors are closely related. Anemia caused by lung cancer is a progressive and not easy to correct anemia, lung cancer prognosis is a bad factor. The authors suggest that caution should be given to chemotherapy for a broad spectrum of patients over the age of 65, and that supportive care should be replaced by enhanced resistance to the body, which may be more beneficial to prolong patients’ lives.